Takami Miki

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

Yasuo Suzuki, Hajime Nawata, Satoshi Soen et al. · Journal of Bone and Mineral Metabolism · 2014 · 290 citations

Medicine, Endocrinology, Orthopedic Surgery +16

FGF-23 in patients with end-stage renal disease on hemodialysis

Yasuo Imanishi, Masaaki Inaba, Kiyoshi Nakatsuka et al. · Kidney International · 2004 · 273 citations

Medicine, Endocrinology, Nephrology +11

Parathyroid Hormone Regulates Fibroblast Growth Factor-23 in a Mouse Model of Primary Hyperparathyroidism

Takehisa Kawata, Yasuo Imanishi, Keisuke Kobayashi et al. · Journal of the American Society of Nephrology · 2007 · 210 citations

Medicine, Endocrinology, Pathobiology +17

High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types

Victor L. Villemagne, Suzuka Ataka, Toshiki Mizuno et al. · Archives of Neurology · 2009 · 174 citations · Full text

Life Sciences, Neurology, Neuroscience +17

<i>Clinical Trials Express:</i>Fracture Risk Reduction With Denosumab in Japanese Postmenopausal Women and Men With Osteoporosis: Denosumab Fracture Intervention Randomized Placebo Controlled Trial (DIRECT)

Toshitaka Nakamura, Toshio Matsumoto, Toshitsugu Sugimoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 168 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17